1) Bladder neoplasms/diagnosis
膀胱肿瘤/诊断
2) bladder neoplasms/DI
膀胱肿瘤/诊断
3) Bladder Neoplasms
膀胱肿瘤
1.
Immunologic adjuvant CpG-ODN to prevent the recurrence of bladder neoplasms;
CpG-ODN预防膀胱肿瘤复发的可行性研究
2.
Objective To compare the level of IL-12 and IL-10 secreted by DC sitimulated with CpG-ODN and BCG,and to investigate the role of new immunologic adjuvant CpG-ODN in preventing the recurrence of bladder neoplasms.
目的比较免疫佐剂卡介苗(BCG)、含CpG序列的寡脱氧核糖核苷酸(CpG-ODN)刺激小鼠骨髓来源的树突状细胞(DC)分泌细胞因子IL-12I、L-10的水平,探讨CpG-ODN在预防膀胱肿瘤复发中的可行性。
3.
Methods The sample was performed on urine exfoliated cell DNA from haematuria, bladder neoplasms and bladder cancer patients by flow cytometry.
方法 利用流式细胞仪对良性血尿、膀胱肿瘤及膀胱癌患者尿脱落细胞进行DNA倍体和SPF分析。
4) Bladder neoplasm
膀胱肿瘤
1.
Relationship between the expression of human telomerase reverse transcriptase and the prognosis in bladder neoplasm;
人端粒酶逆转录酶在膀胱肿瘤中的表达及其与预后的关系
2.
Chromosome aberration of urine exfoliated cells to diagnose bladder neoplasm by fluorescence in situ hybridization
荧光原位杂交检测尿脱落细胞染色体异常诊断膀胱肿瘤的研究
3.
Objective Objective is to investigate the relationship between bladder neck stenosis and bladder neoplasm parameter.
目的探讨膀胱颈口狭窄与膀胱肿瘤的发病关系。
5) Bladder cancer
膀胱肿瘤
1.
Surgical treatment of bladder cancer near ureteral orifice;
输尿管口附近膀胱肿瘤经尿道切除的处理
2.
Photoselective vaporization of superficial bladder cancer;
浅表性膀胱肿瘤的选择性光汽化术
3.
Expressions of basement membrane proteins in bladder cancer and its significance;
膀胱肿瘤中基底膜蛋白的表达和意义
6) Bladder carcinoma
膀胱肿瘤
1.
The clinical observation of transurethral vaporization-electrosection of bladder carcinoma;
经尿道汽化电切治疗膀胱肿瘤的临床观察
2.
Multivariant therapy for invasive,multiple and recrudescent bladder carcinoma(report of 21 cases);
浸润性、多发性和复发性膀胱肿瘤的多元化治疗
3.
Clinical value of Three-dimension Reconstruction with Spiral CT by vesical insufflations in diagnosis of bladder carcinoma
膀胱注气法多层CT三维成像在膀胱肿瘤诊断中的应用
补充资料：膀胱肿瘤
膀胱肿瘤
tumor of bladder
是泌尿生殖系肿瘤中最常见的肿瘤。可分为两大类：一类是从上皮组织发生的肿瘤，包括移行上皮性肿瘤、腺癌及鳞状上皮癌，其中上皮性肿瘤占98%，而移行上皮性肿瘤却占上皮性肿瘤的95%。移行上皮性肿瘤包括乳头状瘤、乳头状癌及实体性癌3种。另一类为从间叶组织发生的肿瘤。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条